CA1078731A - Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique) - Google Patents
Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique)Info
- Publication number
- CA1078731A CA1078731A CA268,001A CA268001A CA1078731A CA 1078731 A CA1078731 A CA 1078731A CA 268001 A CA268001 A CA 268001A CA 1078731 A CA1078731 A CA 1078731A
- Authority
- CA
- Canada
- Prior art keywords
- triethylene tetramine
- phosphonic acid
- methylene phosphonic
- kit
- tetramine hexa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 title claims abstract description 11
- -1 methylene phosphonic acid Chemical compound 0.000 title claims abstract description 11
- 229960001124 trientine Drugs 0.000 title claims abstract description 11
- 238000003384 imaging method Methods 0.000 title description 7
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 229940056501 technetium 99m Drugs 0.000 claims abstract description 6
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 10
- 239000011363 dried mixture Substances 0.000 claims description 10
- 239000001119 stannous chloride Substances 0.000 claims description 10
- 235000011150 stannous chloride Nutrition 0.000 claims description 10
- 150000004683 dihydrates Chemical class 0.000 claims description 5
- 229940102223 injectable solution Drugs 0.000 claims description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 5
- 210000000988 bone and bone Anatomy 0.000 abstract description 9
- 238000009007 Diagnostic Kit Methods 0.000 abstract description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 abstract description 3
- 238000010253 intravenous injection Methods 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940116254 phosphonic acid Drugs 0.000 abstract 1
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000012216 imaging agent Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 101100004166 Mus musculus Bag4 gene Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 101000609457 Trichosanthes kirilowii Trypsin inhibitor 1 Proteins 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- NSNHWTBQMQIDCF-UHFFFAOYSA-N dihydrate;hydrochloride Chemical compound O.O.Cl NSNHWTBQMQIDCF-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940056932 lead sulfide Drugs 0.000 description 1
- 229910052981 lead sulfide Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- QGZKDVFQNNGYKY-NJFSPNSNSA-N nitrogen-16 Chemical compound [16NH3] QGZKDVFQNNGYKY-NJFSPNSNSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA268,001A CA1078731A (fr) | 1976-12-16 | 1976-12-16 | Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique) |
| US05/838,709 US4187284A (en) | 1976-12-16 | 1977-10-03 | Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid) |
| NL7713161A NL7713161A (nl) | 1976-12-16 | 1977-11-29 | Kit voor de bereiding van een injiceerbare tech- netium-99m bevattende oplossing alsmede werkwijze voor het bereiden van een verbeterde injiceerbare oplossing voor beenderbeeldvorming. |
| FR7737497A FR2374014A1 (fr) | 1976-12-16 | 1977-12-13 | Ensemble de fournitures pour la formation d'images du squelette utilisant du triethylene tetramine hexa (acide methylene phosphonique) |
| BE183512A BE861923A (fr) | 1976-12-16 | 1977-12-16 | Ensemble de fournitures pour la formation d'images du squelette utilisant du triethylene tetramine hexa(acide methylene phosphonique) |
| JP15074877A JPS5377016A (en) | 1976-12-16 | 1977-12-16 | Scaffold reflection kit utilizing triethylene tetramine hexa*methylene phosphonate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA268,001A CA1078731A (fr) | 1976-12-16 | 1976-12-16 | Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1078731A true CA1078731A (fr) | 1980-06-03 |
Family
ID=4107511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA268,001A Expired CA1078731A (fr) | 1976-12-16 | 1976-12-16 | Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique) |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4187284A (fr) |
| JP (1) | JPS5377016A (fr) |
| BE (1) | BE861923A (fr) |
| CA (1) | CA1078731A (fr) |
| FR (1) | FR2374014A1 (fr) |
| NL (1) | NL7713161A (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0164843A2 (fr) * | 1984-06-04 | 1985-12-18 | The Dow Chemical Company | Complexes organiques d'acide aminophosphonique pour le traitement de tumeurs calcifiantes |
| US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
| US6767531B2 (en) | 1999-07-11 | 2004-07-27 | Neorx Corporation | High dose radionuclide complexes for bone marrow suppression |
| US7691985B2 (en) | 1999-07-11 | 2010-04-06 | Poniard Pharmaceuticals, Inc. | Skeletal-targeted radiation to treat bone-associated pathologies |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515766A (en) * | 1980-06-23 | 1985-05-07 | The Massachusetts General Hospital | Labeled phosphonic acid compositions for investigations of in vivo deposits of calcium |
| US4504463A (en) * | 1982-06-10 | 1985-03-12 | Mallinckrodt, Inc. | Process for making a lyophilized product for use in skeletal imaging |
| US4504462A (en) * | 1982-06-10 | 1985-03-12 | Mallinckrodt, Inc. | Process for making a lyophilized product for use in skeletal imaging |
| GB8310438D0 (en) * | 1983-04-18 | 1983-05-25 | Amersham Int Plc | Bone-seeking complexes of technetium-99m |
| US4582698A (en) * | 1983-09-19 | 1986-04-15 | The Dow Chemical Company | Process for imaging cardiac infarcts |
| IL74386A (en) * | 1984-02-27 | 1988-12-30 | Dow Chemical Co | Bis(aminomethyl)bicyclo(2.2.1)heptanes useful as metal ion control agents |
| US4560548A (en) * | 1984-04-10 | 1985-12-24 | The Dow Chemical Company | Bone seeking Tc-99m complexes of phosphonate derivatives of bis(aminoalkyl)piperazine |
| US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
| JPS6117596A (ja) * | 1984-07-03 | 1986-01-25 | Fujisawa Pharmaceut Co Ltd | ホスミドマイシンまたはその塩類の凍結乾燥粉体およびその製造法 |
| FR2636632B1 (fr) * | 1988-09-16 | 1996-02-02 | Oris Ind | Produits radiopharmaceutiques constitues par des complexes de tc, re ou y comportant des ligands tetraphosphonates et leur preparation |
| WO2002062398A2 (fr) | 2001-01-08 | 2002-08-15 | Neorx Corporation | Composes, compositions et methodes therapeutiques et diagnostiques |
| US20060008422A1 (en) * | 2004-01-09 | 2006-01-12 | Abraham Araya | Dentifrice compositons and abrasive systems |
| GB0400408D0 (en) * | 2004-01-09 | 2004-02-11 | Ineos Silicas Ltd | Dentifrice compositions containing zeolites |
| DE102014210378B4 (de) | 2014-06-02 | 2018-10-04 | Zschimmer & Schwarz Mohsdorf GmbH &Co.KG. | Verfahren zur Herstellung hochreiner Aminoalkylenphosphonsäuren |
| WO2019211464A1 (fr) | 2018-05-04 | 2019-11-07 | Gmp-Orphan Sa | Forme cristalline du tétrachlorhydrate de triéthylènetétramine et utilisation pharmaceutique correspondante |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2017974A1 (de) * | 1970-04-15 | 1971-11-04 | Joh. A. Benckiser Gmbh Chemische Fabrik, 6700 Ludwigshafen | Verfahren zur Herstellung von Aminoalkylenphosphonsäuren |
| US3983227A (en) * | 1973-05-23 | 1976-09-28 | The Procter & Gamble Company | Dry mixture containing diphosphonates and a stannous salt useful in the preparation of Tc99M containing bone scanning agents |
| CA1027135A (fr) * | 1973-06-11 | 1978-02-28 | Research Corporation | Complexe de technetium-99m se fixant dans le tissu osseux |
| US3974268A (en) * | 1975-05-30 | 1976-08-10 | Research Corporation | Bone-seeking technetium-99m imidodiphosphonate complex |
| US4017595A (en) * | 1975-08-28 | 1977-04-12 | Research Corporation | Bone-seeking indium-113m or indium-111 organic phosphonate complexes |
-
1976
- 1976-12-16 CA CA268,001A patent/CA1078731A/fr not_active Expired
-
1977
- 1977-10-03 US US05/838,709 patent/US4187284A/en not_active Expired - Lifetime
- 1977-11-29 NL NL7713161A patent/NL7713161A/xx not_active Application Discontinuation
- 1977-12-13 FR FR7737497A patent/FR2374014A1/fr active Granted
- 1977-12-16 JP JP15074877A patent/JPS5377016A/ja active Pending
- 1977-12-16 BE BE183512A patent/BE861923A/fr unknown
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0164843A2 (fr) * | 1984-06-04 | 1985-12-18 | The Dow Chemical Company | Complexes organiques d'acide aminophosphonique pour le traitement de tumeurs calcifiantes |
| EP0164843A3 (en) * | 1984-06-04 | 1987-09-23 | The Dow Chemical Company | Organic amine phosphonic acid complexes for the treatment of calcific tumors |
| US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
| US5300279A (en) * | 1984-06-04 | 1994-04-05 | The Dow Chemical Company | Organic amine phosphonic acid complexes for the treatment of calcific tumors |
| US6767531B2 (en) | 1999-07-11 | 2004-07-27 | Neorx Corporation | High dose radionuclide complexes for bone marrow suppression |
| US7691985B2 (en) | 1999-07-11 | 2010-04-06 | Poniard Pharmaceuticals, Inc. | Skeletal-targeted radiation to treat bone-associated pathologies |
| US7696331B2 (en) | 1999-07-11 | 2010-04-13 | Poniard Pharmaceuticals, Inc. | High dose radionuclide complexes for bone marrow treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7713161A (nl) | 1978-06-20 |
| US4187284A (en) | 1980-02-05 |
| FR2374014B1 (fr) | 1980-04-04 |
| FR2374014A1 (fr) | 1978-07-13 |
| BE861923A (fr) | 1978-06-16 |
| JPS5377016A (en) | 1978-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1078731A (fr) | Kit de radiographie des os, utilisant le triethylene tetramine hexa (acide methylenephosphonique) | |
| Subramanian et al. | 99mTc-labeled polyphosphate as a skeletal imaging agent | |
| Subramanian et al. | A New Complex of 99mTc for Skeletal Imaqinq | |
| Abrams et al. | Metal compounds in therapy and diagnosis | |
| JP2515929B2 (ja) | 巨環アミノホスホン酸錯体，その製造，製剤化及び使用 | |
| CA1143285A (fr) | Agent de scintigraphie | |
| EP0096930B1 (fr) | Agents de visualisation radiographique stables | |
| US4104366A (en) | Compositions for preparation of aqueous solutions of low valence 99 technitium salts | |
| US4054645A (en) | Radiodiagnostic complexes employing fluorine-containing tin reducing agents | |
| JPS5885823A (ja) | テクネチウム−９９ｍを基にした放射性診断剤 | |
| JPS5989635A (ja) | シンチグラフイ−のためのテクネチウム−９９ｍ−トリ−およびテトラ−ホスホン酸塩およびそれらの調製方法 | |
| US3852414A (en) | Bone seeking technetium 99m stannous phosphate complex | |
| JPS6126887B2 (fr) | ||
| KR850001870B1 (ko) | 비-방사성 담체조성물 및 이를 사용한 골주사용(骨走査用) 방사성 진단제의 제조방법 | |
| US3931396A (en) | Method of preparation of a composition having a base of 99m technetium for diagnosis by scintigraphy | |
| JPS595123A (ja) | 骨格造影に使用する凍結乾燥製品の製造方法 | |
| US3735001A (en) | Technetium bone scanning medium | |
| EP0169232B1 (fr) | Composition pour le marquage au technetium -99m de matières protéiques | |
| US3928552A (en) | Hepato-biliary radiopharmaceutical comprising 2-mercaptoisobutyric acid chelating reduced technetium-99m | |
| CA1324317C (fr) | Produits radiodiagnostiques stables, mode de preparation | |
| EP2351758B1 (fr) | Complexes métalliques, procédé de production de ces derniers, et agents radio-pharmaceutiques les utilisant | |
| CA1227214A (fr) | Obtention de complexes de metaux radioactifs avec des derives phosphonates de dicyclopentadienebis(methylamine) | |
| CA1072010A (fr) | Agent de diagnostic marque au technetium-99m pour l'examen des reins par scintigraphie et procede de preparation | |
| JPS5946229A (ja) | 骨格造影に使用する凍結乾燥製品の製造法 | |
| US4318898A (en) | Technetium-99m-labelled (2,4,5-trimethylacetanilido)-iminodiacetate for liver function diagnosis, chloroacetric acid (2,4,5-trimethylanilide), (2,4,5-trimethylacetanilido)-iminodiacetate, and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |